Antibiotic susceptibility of blood culture isolates after nearly two decades with netilmicin and ampicillin in neonatal septicaemia
Corresponding Author
A. RØNNESTAD
Department of Paediatrics, The National Hospital, Oslo, Norway
Department of Paediatrics, The National Hospital, Pilestredet 32, N-0027 Oslo, Norway.Search for more papers by this authorT. G. ABRAHAMSEN
Department of Paediatrics, The National Hospital, Oslo, Norway
Search for more papers by this authorP. GAUSTAD
Institute of Medical Microbiology, The National Hospital, Oslo, Norway
Search for more papers by this authorP. H. FINNE
Department of Paediatrics, The National Hospital, Oslo, Norway
Search for more papers by this authorCorresponding Author
A. RØNNESTAD
Department of Paediatrics, The National Hospital, Oslo, Norway
Department of Paediatrics, The National Hospital, Pilestredet 32, N-0027 Oslo, Norway.Search for more papers by this authorT. G. ABRAHAMSEN
Department of Paediatrics, The National Hospital, Oslo, Norway
Search for more papers by this authorP. GAUSTAD
Institute of Medical Microbiology, The National Hospital, Oslo, Norway
Search for more papers by this authorP. H. FINNE
Department of Paediatrics, The National Hospital, Oslo, Norway
Search for more papers by this authorAbstract
The aim of the study was to investigate the in vitro antibiotic susceptibility of blood culture isolates after almost 20 years with ampicillin and methicillin as empirical treatment for neonatal septicaemia. All blood culture isolates and their antibiograms obtained in a single tertiary neonatal intensive care unit from 1 January 1989 to 31 December 1994 were reviewed. Two hundred and six blood cultures from 181 infants containing 223 bacterial and 11 fungal isolates were identified during 4416 admissions. Fifteen (6.7%) of the bacterial isolates were resistant to ampicillin and netilmicin. Fourteen per cent of the staphylococcal spp. were susceptible to penicillin while more than 90% were susceptible to netilmicin. The coagulase-negative staphylococci (CONS) were resistant to netilmicin, methicillin and gentamicin in 12%, 49% and 65%, respectively. Eighty-nine per cent of the methicillin-resistant CONS were susceptible to netilmicin as opposed to 17% to gentamicin (p<0.001). Except for one strain of Acinetobacter sp., all Gram-negative bacteria were susceptible to netilmicin. Our data show that the ampicillin-netilmicin combination still provides a high in vitro coverage (93%) against bacteria identified in blood cultures from newborns in our unit. Netilmicin has a significantly better in vitro effectiveness against CONS than gentamicin.
REFERENCES
- 1
Barrow, G. I. &
Feltham, R. K. A.: Cowan and Steel's Manual for the Identification of Medical Bacteria. Cambridge University Press,
England
1993.
10.1017/CBO9780511527104 Google Scholar
- 2 Battisti, O., Mitchison, R. & Davies, P.: Changing blood culture isolates in a referral neonatal intensive care unit. Arch. Dis. Child. 56: 775–778, 1981.
- 3 Bennet, R., Eriksson, M. & Zetterström, R.: Increasing incidence of neonatal septicaemia: Causative organism and predisposing factors. Acta Paediatr. 70: 207–210, 1981.
- 4 Bennet, R., Eriksson, M., Melen, B. & Zetterström, R.: Changes in the incidence and spectrum of neonatal septicaemia during a fifteen-year period. Acta Paediatr. 74: 687–690, 1985.
- 5 Bergan, T., Bruun, J. N., Digrams, A., Lingaas, E., Melby, K. K. & Sander, J.: Susceptibility testing of bacteria and fungi. Report from “the Norwegian Working Group on Antibiotics”. Scand. J. Infect. Dis. (Suppl.) 103: 20–33, 1997.
- 6 Bonten, M. J., Hayden, M. K., Nathan, C., Voorhis, J. van, Mathushek, M., Slaughter, S. et al.: Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348: 1615–1619, 1996.
- 7 Brown, K. N., Benedictson, J. & Swanby, S.: In vitro comparison of gentamicin, tobramycin, sisomicin and netilmicin. Antimicrob. Agents Chemother. 10: 768–769, 1976.
- 8 Chavanet, P., Collin, F., Muggeo, E., Gagelin, B. B., Chassin, P., Kosmidis, V. et al: The in-vivo activity of co-amoxiclav with netilmicin against experimental methicillin and gentamicin resistant Staphylococcus epidermidis infection in rabbits. J. Antimicrob. Chemother. 31: 129–138, 1993.
- 9 Courvalin, P.: Impact of molecular biology on antibiotic susceptibility: testing and therapy. Am. J. Med. (Suppl. 6 A); 99: 21S–25S, 1995.
- 10 de Louvois, J., Dagan, R. & Tessin, I.: A comparison of ceftazidim and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. Eur. J. Pediatr. 151: 876–884, 1992.
- 11 Donowitz, L. G., Haley, C. E., Gregory, W. W. & Wentzel, R. P.: Neonatal intensive care unit bacteremia: emergence of gram-positive bacteria as major pathogens. Am. J. Infect. Control 15: 141–147, 1987.
- 12 Dornbusch, K., Miller, G. H., Hare, R. S. & Shaw, K. J.: Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group On Antibiotic Resistance). J. Antimicrob. Chemother. 26: 131–144, 1990.
- 13 Eden, T., Skansberg, P. & Haeger, K.: Netilmicin in severe infections; a randomized comparison with gentamicin. Curr. Ther. Res. 24: 96–107, 1978.
- 14
Fanos, V.,
Verlato, G.,
DalMoro, A.,
Chiattoni, G. P. &
Padovani, E. M.: Staphylococcus epidermidis isolation and antibiotic resistance in a neonatal intensive care unit.
J. Chemother.
1: 26–29, 1995.
10.1179/joc.1995.7.1.26 Google Scholar
- 15 Fu, K. P. & Neu, H. C.: In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob. Agents Chemother. 10: 511–518, 1976.
- 16 Hall, R. T., Kurth, C. G. & Hall, S. L.: Ten-year survey of positive blood cultures among admissions to a neonatal intensive care unit. J. Perinatal. 7: 122–126, 1987.
- 17 Haug, J. B., Harthug, S., Kalager, T., Digranes, A. & Solberg, C. O.: Bloodstream infection at a Norwegian University Hospital, 1974–1979 and 1988–1989: changing etiology, clinical features, and outcome. Clin. Infect. Dis. 19: 246–256, 1994.
- 18 Isenberg, H. D.: Clinical Microbiology Procedures Handbook. American Society for Microbiology, Washington , USA 1992.
- 19 Jarløv, J. O., Højberg, T., Busch-Sørensen, C., Scheibel, J., Møller, J. K., Kolmos, H. J. J. & Wandall, D. A.: Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. J. Hosp. Infect. 32: 217–227, 1996.
- 20 Krediet, T. G., Fleer, A. & Gerards, L. J.: Development of resistance to aminoglycosides among coagulase-negative staphylococci and enterobacteriaceae in a neonatal intensive care unit. J. Hosp. Infect. 24: 39–46, 1993.
- 21 Mandell, Douglas and Bennett's Principles and Practise of Infectious Diseases, 4th ed. Churchill Livingstone, 1995, p. 284.
- 22 Munson, D. P., Thompson, T. R., Johnson, D. E., Rhame, F. S., VanDrunen, N. & Ferreiri, P.: Coagulase-negative staphylococcal septicaemia: experience in a newborn intensive care unit. J. Pediatr. 101: 602–605, 1982.
- 23 Perdikaris, G., Giamarellou, H., Pefanis, A., Donta, I. & Karayiannakos, P.: Vancomycin or vancomycin plus netilmicin for methicillin-and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Antimicrob. Agents Chemother. 39: 2289–2294, 1995.
- 24 National Committee on Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. Eighth International Supplement, 18 (1). Villanova 1993.
- 25 Placzek, M. M. & Whitelaw, A.: Early and late neonatal septicaemia. Arch. Dis. Child. 58: 728–31, 1983.
- 26 Pærregaard, A. & Bruun, B. G.: Neonatal septicaemia at Rigshospitalet 1984–1988. Ugeskr. Læger 153: 195–197, 1991.
- 27 Rahal, J. J., Simberkoff, M. S., Kagan, K. & Moldover, N. H.: Bacterial efficacy of Sch20569 and amikacin against gentamicin-sensitive and-resistant organisms. Antimicrob. Agents Chemother. 9: 595–600, 1976.
- 28 Rønnestad, A., Abrahamsen, T. G., Gaustad, P. & Finne, P. H.: Blood culture isolates in sick neonates: a 6 year experience of a Norwegian neonatal intensive care unit. Scand J. Inf. Dis. 30: 245–251, 1998.
- 29 Schmidt, B. K., Kirplani, H. M., Corey, M., Low, D. E., Alistar, P. A. G. & Ford-Jones, E. L.: Coagulase-negative staphylococci as true pathogens in newborn infants: a cohort study. Pediatr. Infect. Dis. J. 6: 1026–1031, 1987.
- 30 Stoll, B. & Fanaroff, A.: Early-onset coagulase-negative staphylococcal sepsis in preterm neonate. Lancet 345: 1236–1237, 1995.
- 31 Stoll, B. J., Gordon, T., Korones, S. B., Shankaran, S., Tyson, J. E. et al.: Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Network. J. Pediatr. 129: 72–80, 1996.
- 32 Stoll, B. J., Gordon, T., Korones, S. B., Shankaran, S., Tyson, J. E. et al.: Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Network. J. Pediatr. 129: 63–71, 1996.
- 33 Tessin, I., Trollfors, B., Thringer, K. & Larsson, P.: Ampicillin-aminiglycoside combinations as initial treatment for neonatal septicaemia or meningitis. Acta Paediatr. 80: 911–916, 1991.
- 34 Tullus, K. & Burman, L. G.: Ecological impact of ampicillin and cefuroxim in neonatal units. Lancet 1: 1405–1407, 1989.
- 35 Tullus, K., Olsson-Liljequist, B., Lundstrøm, G. & Burman, L. G.: Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications. Acta Pædiatr. Scand. 80: 205–212, 1991.
- 36 Vesakari, T., Janas, M., Grönros, P. & Tupparainen, N.: Neonatal septicaemia. Arch. Dis. Child. 60: 542–546, 1985.
- 37 Word, B. M. & Klein, J. O.: Therapy of bacterial sepsis and meningitis in infants and children: 1989 poll of directors of programs in pediatric infectious diseases. Pediatr. Infect. Dis. 8: 635–637, 1989.
